These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 14666900)

  • 21. FDA's role in making exclusivity determinations.
    Dickinson EH
    Food Drug Law J; 1999; 54(2):195-203. PubMed ID: 11758573
    [No Abstract]   [Full Text] [Related]  

  • 22. FDA notifications. FDA grants approval for generic didanosine for oral solution.
    AIDS Alert; 2007 May; 22(5):58-9. PubMed ID: 17577960
    [No Abstract]   [Full Text] [Related]  

  • 23. Initial responses to recommendations of the Blue Ribbon Committee on Generic Medicines.
    Heller WM
    Am J Hosp Pharm; 1993 Feb; 50(2):318-22. PubMed ID: 8480792
    [No Abstract]   [Full Text] [Related]  

  • 24. Should you go generic?
    Carmichael M
    Newsweek; 2008 Oct; 152(15):78. PubMed ID: 18975394
    [No Abstract]   [Full Text] [Related]  

  • 25. Old drugs, new uses: solving a Hatch-Waxman patent predicament.
    McPhie DC
    Food Drug Law J; 2004; 59(1):155-68. PubMed ID: 15190929
    [No Abstract]   [Full Text] [Related]  

  • 26. Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Sep; 73(189):56487-91. PubMed ID: 18985960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FDA notifications. Generic emtricitabine approved by FDA.
    AIDS Alert; 2008 Jul; 23(7):80. PubMed ID: 18688996
    [No Abstract]   [Full Text] [Related]  

  • 28. FDA notifications. FDA approves generic AZT.
    AIDS Alert; 2007 Jul; 22(7):79. PubMed ID: 17763553
    [No Abstract]   [Full Text] [Related]  

  • 29. FDA notifications. FDA approves generic lamivudine.
    AIDS Alert; 2008 Dec; 23(12):142. PubMed ID: 19110688
    [No Abstract]   [Full Text] [Related]  

  • 30. Current regulatory and legal considerations for follow-on biologics.
    Kingham RF; Lietzan E
    Clin Pharmacol Ther; 2008 Nov; 84(5):633-5. PubMed ID: 18716615
    [No Abstract]   [Full Text] [Related]  

  • 31. Biogenerics standoff.
    Herrera S
    Nat Biotechnol; 2004 Nov; 22(11):1343-6. PubMed ID: 15529145
    [No Abstract]   [Full Text] [Related]  

  • 32. FDA notifications. Tentative approval of generic lamivudine.
    AIDS Alert; 2005 Jul; 20(7):82. PubMed ID: 16114112
    [No Abstract]   [Full Text] [Related]  

  • 33. FDA notifications. FDA tentatively approves generic lamivudine.
    AIDS Alert; 2007 May; 22(5):57. PubMed ID: 17580368
    [No Abstract]   [Full Text] [Related]  

  • 34. Biosimilars legislation awakens data exclusivity debate.
    Hutson S
    Nat Med; 2009 Nov; 15(11):1242. PubMed ID: 19893548
    [No Abstract]   [Full Text] [Related]  

  • 35. Epo, by any other name.
    Nature; 2007 Sep; 449(7160):259. PubMed ID: 17882170
    [No Abstract]   [Full Text] [Related]  

  • 36. Multisource drugs: implications and concerns in the geriatric population.
    Gerbino PP; Joseph AS
    Hosp Pharm; 1993 Feb; 28(2):96-8, 101-2. PubMed ID: 10125706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FDA notifications. FDA tentatively approves generic atazanavir.
    AIDS Alert; 2008 Mar; 23(3):32. PubMed ID: 18661639
    [No Abstract]   [Full Text] [Related]  

  • 38. FDA notifications. FDA approval for generic lamivudine/zidovudine.
    AIDS Alert; 2008 Jan; 23(1):12. PubMed ID: 18572476
    [No Abstract]   [Full Text] [Related]  

  • 39. FDA notifications. Generic emtricitabine is approved by the FDA.
    AIDS Alert; 2009 Feb; 24(2):21. PubMed ID: 19222147
    [No Abstract]   [Full Text] [Related]  

  • 40. FDA notifications. FDA approved 3 generic formulations of stavudine.
    AIDS Alert; 2009 Feb; 24(2):21. PubMed ID: 19219951
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.